{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:13:19Z","timestamp":1787724799736,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.semnephrol.2004.06.007","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T13:22:07Z","timestamp":1222003327000},"page":"441-445","source":"Crossref","is-referenced-by-count":14,"title":["Chronic systemic inflammation in uremia: Potential therapeutic approaches"],"prefix":"10.1016","volume":"24","author":[{"given":"Gianfranco","family":"Guarnieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Biolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Barazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2004.06.007_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1992.332","article-title":"Plasma tumor necrosis factor soluble receptors in chronic renal failure","volume":"42","author":"Brockhaus","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/jren.2003.50021","article-title":"Inflammation in ESRD","volume":"13","author":"Kaysen","year":"2003","journal-title":"J Ren Nutr"},{"issue":"suppl","key":"10.1016\/j.semnephrol.2004.06.007_bib5","first-page":"S41","article-title":"Mechanisms of malnutrition in uremia","volume":"62","author":"Guarnieri","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1046\/j.1523-1755.1999.00410.x","article-title":"Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients","volume":"55","author":"Ikizler","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/jren.2003.50020","article-title":"Mechanisms of malnutrition in uremia","volume":"13","author":"Guarnieri","year":"2003","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000014479","article-title":"Inflammatory and atherosclerotic interactions in the depleted uremic patient","volume":"19","author":"Stenvinkel","year":"2001","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1755.2002.00504.x","article-title":"Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events","volume":"62","author":"Girndt","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/ki.1994.187","article-title":"Skeletal muscle protein synthesis and degradation in patients with chronic renal failure","volume":"45","author":"Garibotto","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00075197-200207000-00005","article-title":"Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings","volume":"5","author":"Marette","year":"2002","journal-title":"Clin Nutr Metab Care"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1755.2000.00181.x","article-title":"Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients","volume":"58","author":"Memoli","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1525-139X.2002.00065.x","article-title":"The pathology of dialysis","volume":"15","author":"Freemont","year":"2002","journal-title":"Semin Dial"},{"issue":"suppl","key":"10.1016\/j.semnephrol.2004.06.007_bib15","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1046\/j.1523-1755.63.s84.19.x","article-title":"Relationship between advanced glycoxidation end products, inflammatory markers\/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients","volume":"84","author":"Kalousova","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000063558","article-title":"Immune system dysregulation in uremia","volume":"20","author":"Descamps-Latscha","year":"2002","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib17","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1046\/j.1523-1755.2001.00998.x","article-title":"Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia","volume":"60","author":"Mezzano","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/089686080302300207","article-title":"C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis","volume":"23","author":"Paniagua","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0049-3848(02)00401-2","article-title":"Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures. Effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin","volume":"108","author":"Lindmark","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/phrs.2001.0922","article-title":"Modulation of inflammatory mediators and PPAR\u03b3 and NF\u03baB expression by pravastatin in response to lipoproteins in human monocytes in vitro","volume":"45","author":"Zelvyte","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.ATV.0000030997.02059.BB","article-title":"Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease","volume":"22","author":"Koh","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1053\/ajkd.2002.33393","article-title":"Effects of simvastatin on high sensitivity C-reactive protein and serum albumin in hemodialysis patients","volume":"39","author":"Chang","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib25","first-page":"238","article-title":"Atorvastatin and simvastatin in patients on hemodialysis","volume":"16","author":"van den Akker","year":"2003","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1006\/bbrc.1999.0543","article-title":"Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes","volume":"257","author":"Kranzhofer","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib27","first-page":"F777","article-title":"Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis","volume":"280","author":"Guo","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0735-1097(99)00594-X","article-title":"Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure","volume":"35","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0735-1097(00)01138-4","article-title":"Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis","volume":"37","author":"Navalkar","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2796.1999.00560.x","article-title":"Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure","volume":"246","author":"Stenvinkel","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(90)90474-6","article-title":"Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality","volume":"47","author":"Noel","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib32","first-page":"E660","article-title":"Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis","volume":"265","author":"Breuill\u00e9","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/ajkd.2002.36864","article-title":"Pentoxifylline acutely reduces protein catabolism in chronically uremic patients","volume":"40","author":"Biolo","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.CIR.0000044387.23578.E9","article-title":"C-reactive protein and ischemia in users and nonusers of beta-blockers and statins","volume":"107","author":"Beattie","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mhj.2002.125628","article-title":"Effect of thalidomide in patients with chronic heart failure","volume":"144","author":"Gullestad","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib38","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A controlled trial of fish oil in IgA nephropathy","volume":"331","author":"Donadio","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib39","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.V10102177","article-title":"Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients","volume":"10","author":"Ando","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib40","first-page":"157","article-title":"N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease","volume":"10","author":"Cappelli","year":"1997","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib41","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/hq1001.096645","article-title":"L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism","volume":"21","author":"Vermeersch","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1681\/ASN.V122361","article-title":"L-arginine supplementation improves function and reduces inflammation in renal allografts","volume":"12","author":"Vos","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1681\/ASN.V441039","article-title":"L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats","volume":"4","author":"Reyes","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib44","first-page":"R1768","article-title":"Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function","volume":"272","author":"Reckelhoff","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1046\/j.1523-1755.2002.00268.x","article-title":"L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation","volume":"61","author":"Schramm","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib46","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.ATV.19.5.1168","article-title":"Nitric oxide production is reduced in patients with chronic renal failure","volume":"19","author":"Wever","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0021-9150(02)00206-X","article-title":"Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin","volume":"166","author":"Eid","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib49","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease","volume":"10","author":"Kielstein","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00075197-200303000-00013","article-title":"L-glycine","volume":"6","author":"Zhong","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1440-1681.2002.03683.x","article-title":"Effects of glycine on glomerular filtration rate and segmental tubular handling of sodium in conscious rats","volume":"29","author":"Thomsen","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib53","first-page":"F417","article-title":"Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo","volume":"282","author":"Yin","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib54","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bjc.1995.482","article-title":"Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock","volume":"72","author":"Winter","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib55","doi-asserted-by":"crossref","first-page":"C802","DOI":"10.1152\/ajpcell.00046.2002","article-title":"L-carnitine","volume":"283","author":"Vescovo","year":"2002","journal-title":"Am J Physiol"},{"issue":"suppl","key":"10.1016\/j.semnephrol.2004.06.007_bib56","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/ajkd.2001.27408","article-title":"Carnitine metabolism in uremia","volume":"38","author":"Guarnieri","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000045993","article-title":"Effect of L-carnitine supplementation in hemodialysis patients","volume":"88","author":"Vesela","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1034\/j.1600-0838.2003.20218.x","article-title":"Possible beneficial role of exercise in modulating low-grade inflammation in the elderly","volume":"13","author":"Pedersen","year":"2003","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib59","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2004.06.007_bib60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1096\/fj.00-0274com","article-title":"Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans","volume":"15","author":"Greiwe","year":"2001","journal-title":"FASEB J"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:11:04Z","timestamp":1631833864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929504000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0270929504000907"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2004.06.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}